Clarinex is part of a class of drugs called antihistamines. As the name implies, the drug blocks the effects of histamine. This can help with relief of allergy symptoms. However, since histamine is not involved with nasal congestion, Clarinex will not help open the nasal passages.
Schering Plough and Sepracor have settled a patent dispute with Indian generics maker Dr. Reddy's over Clarinex. The settlement brings forward the end of patent exclusivity on Clarinex to 2012. Previously, the assumption had been that Schering's exclusivity with Clarinex would last until 2020.
SCHERING-Plough Corp. is said to be negotiating final terms of a consent decree with the Food & Drug Administration over manufacturing woes, which prevent a Clarinex launch. ... SCHERING-Plough Corp. is said to be negotiating final terms of a consent decree with the Food...
|
